COZAAR

This brand name is authorized in United States. It is also authorized in Brazil, Canada, Croatia, Cyprus, Ecuador, Finland, France, Germany, Hong Kong SAR China, Ireland, Mexico, Netherlands, Poland, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug COZAAR contains one active pharmaceutical ingredient (API):

1	Losartan UNII 3ST302B24A - LOSARTAN POTASSIUM
	Losartan is a synthetic oral angiotensin-II receptor (type AT1) antagonist. Antihypertensive activity and suppression of plasma aldosterone concentration are maintained, indicating effective angiotensin II receptor blockade.
	Read more about Losartan

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
COZAAR Powder and solvent for oral suspension	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
COZAAR Film-coated tablets	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
COZAAR Film-coated tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09CA01	Losartan	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09C Angiotensin II antagonists, plain → C09CA Angiotensin II antagonists, plain
Discover more medicines within C09CA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	525500601116311, 525500605111312, 525500606118310
CA	Health Products and Food Branch	02182815, 02182874, 02182882
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00634070
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	24.355-1-01-12, 366780713
ES	Centro de información online de medicamentos de la AEMPS	60913, 62117, 64971
FI	Lääkealan turvallisuus- ja kehittämiskeskus	006928, 079061
FR	Base de données publique des médicaments	66928996, 69197614
GB	Medicines & Healthcare Products Regulatory Agency	13583, 13584, 138569, 138571, 142112, 151391, 180547, 198701, 373503, 373620, 374050, 381275, 399367, 94152
HK	Department of Health Drug Office	39953, 50281
HR	Agencija za lijekove i medicinske proizvode	HR-H-174024498, HR-H-243903537
IE	Health Products Regulatory Authority	19020, 19042, 19051, 19065, 19252, 19257, 76510, 76511, 76529
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	284M95
NL	Z-Index G-Standaard, PRK	41890, 60569
PL	Rejestru Produktów Leczniczych	100016067, 100113936, 100124555
SG	Health Sciences Authority	08588P, 11614P
TR	İlaç ve Tıbbi Cihaz Kurumu	8683280337053, 8683280337060
US	FDA, National Drug Code	0006-0951, 0006-0952, 0006-0960, 55289-238
ZA	Health Products Regulatory Authority	29/7.1.3/0268, 36/7.1.3/0490